Advertisement

Index by author

July 01, 1980; Volume 8,Issue 4

A

  1. Abraham, R T

    1. Factors influencing dimethylphenobarbital N-demethylation by isolated hepatocytes from untreated and phenobarbital-treated rats.
      M E Sauers, R T Abraham, J D Alvin and M A Zemaitis
      Drug Metabolism and Disposition July 1980, 8 (4) 208-211;

  2. Agoh, T

    1. Metabolism and disposition of peptido-aminobenzophenone (2-o-chlorobenzoyl-4-chloro-N-methyl-N-glycylglycinanilide) and its major benzodiazepine metabolites in dogs.
      M Konishi, T Agoh, T Sato, R Konaka and Y Mori
      Drug Metabolism and Disposition July 1980, 8 (4) 253-259;

  3. Ahokas, J T

    1. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
      O Pelkonen, E Sotaniemi, O Tokola and J T Ahokas
      Drug Metabolism and Disposition July 1980, 8 (4) 218-222;

  4. Allen, J R

    1. 2,2',5,5'-Tetrachlorobiphenyl: isolation and identification of metabolites generated by rat liver microsomes.
      B D Preston and J R Allen
      Drug Metabolism and Disposition July 1980, 8 (4) 197-204;

  5. Alvin, J D

    1. Factors influencing dimethylphenobarbital N-demethylation by isolated hepatocytes from untreated and phenobarbital-treated rats.
      M E Sauers, R T Abraham, J D Alvin and M A Zemaitis
      Drug Metabolism and Disposition July 1980, 8 (4) 208-211;

B

  1. Betlach, C J

    1. Biodisposition of theophylline. I. Genetic variation in inbred mice.
      C J Betlach and T N Tozer
      Drug Metabolism and Disposition July 1980, 8 (4) 268-270;
    2. Biodisposition of theophylline. II. Effect of aromatic hydrocarbon treatment in mice.
      C J Betlach and T N Tozer
      Drug Metabolism and Disposition July 1980, 8 (4) 271-273;

  2. Bhuta, S I

    1. Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog.
      J G Dain, S I Bhuta, R A Coombs, K C Talbot and H A Dugger
      Drug Metabolism and Disposition July 1980, 8 (4) 247-252;

  3. Bius, D L

    1. Gas chromatographic-mass spectrometric studies on the metabolic fate of ethotoin in man.
      D L Bius, W D Yonekawa, H J Kupferberg, F Cantor and K H Dudley
      Drug Metabolism and Disposition July 1980, 8 (4) 223-229;

C

  1. Cantor, F

    1. Gas chromatographic-mass spectrometric studies on the metabolic fate of ethotoin in man.
      D L Bius, W D Yonekawa, H J Kupferberg, F Cantor and K H Dudley
      Drug Metabolism and Disposition July 1980, 8 (4) 223-229;

  2. Coombs, R A

    1. Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog.
      J G Dain, S I Bhuta, R A Coombs, K C Talbot and H A Dugger
      Drug Metabolism and Disposition July 1980, 8 (4) 247-252;

D

  1. Dain, J G

    1. Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog.
      J G Dain, S I Bhuta, R A Coombs, K C Talbot and H A Dugger
      Drug Metabolism and Disposition July 1980, 8 (4) 247-252;

  2. Dean, M

    1. Antipyrine pharmacokinetics in the pregnant rat.
      M Dean, L O'Donnell, S Penglis and B Stock
      Drug Metabolism and Disposition July 1980, 8 (4) 265-267;

  3. deLuna, F A

    1. Timolol metabolism in man and laboratory anamals.
      D J Tocco, A E Duncan, F A deLuna, J L Smith, R W Walker and W J Vandenheuvel
      Drug Metabolism and Disposition July 1980, 8 (4) 236-240;

  4. Di Carlo, F J

    1. Undifferentiated radioactivity revisited.
      F J Di Carlo
      Drug Metabolism and Disposition July 1980, 8 (4) 287-288;

  5. Dudley, K H

    1. Gas chromatographic-mass spectrometric studies on the metabolic fate of ethotoin in man.
      D L Bius, W D Yonekawa, H J Kupferberg, F Cantor and K H Dudley
      Drug Metabolism and Disposition July 1980, 8 (4) 223-229;

  6. Duggan, D E

    1. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
      D E Duggan, K F Hooke and S S Hwang
      Drug Metabolism and Disposition July 1980, 8 (4) 241-246;

  7. Dugger, H A

    1. Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog.
      J G Dain, S I Bhuta, R A Coombs, K C Talbot and H A Dugger
      Drug Metabolism and Disposition July 1980, 8 (4) 247-252;

  8. Duncan, A E

    1. Timolol metabolism in man and laboratory anamals.
      D J Tocco, A E Duncan, F A deLuna, J L Smith, R W Walker and W J Vandenheuvel
      Drug Metabolism and Disposition July 1980, 8 (4) 236-240;

F

  1. Fenselau, C

    1. Analysis of intact glucuronides by mass spectrometry and gas chromatography-mass spectrometry. A review.
      C Fenselau and L P Johnson
      Drug Metabolism and Disposition July 1980, 8 (4) 274-283;

  2. Friederici, D E

    1. Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity.
      R Kahl, D E Friederici, G F Kahl, W Ritter and R Krebs
      Drug Metabolism and Disposition July 1980, 8 (4) 191-196;

G

  1. Gaver, R C

    1. Disposition of parenteral butorphanol in man.
      R C Gaver, M Vasiljev, H Wong, I Monkovic, J E Swigor, D R Van Harken and R D Smyth
      Drug Metabolism and Disposition July 1980, 8 (4) 230-235;

H

  1. Hooke, K F

    1. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
      D E Duggan, K F Hooke and S S Hwang
      Drug Metabolism and Disposition July 1980, 8 (4) 241-246;

  2. Hwang, S S

    1. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
      D E Duggan, K F Hooke and S S Hwang
      Drug Metabolism and Disposition July 1980, 8 (4) 241-246;

J

  1. Johnson, L P

    1. Analysis of intact glucuronides by mass spectrometry and gas chromatography-mass spectrometry. A review.
      C Fenselau and L P Johnson
      Drug Metabolism and Disposition July 1980, 8 (4) 274-283;

K

  1. Kahl, G F

    1. Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity.
      R Kahl, D E Friederici, G F Kahl, W Ritter and R Krebs
      Drug Metabolism and Disposition July 1980, 8 (4) 191-196;

  2. Kahl, R

    1. Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity.
      R Kahl, D E Friederici, G F Kahl, W Ritter and R Krebs
      Drug Metabolism and Disposition July 1980, 8 (4) 191-196;

  3. Konaka, R

    1. Metabolism and disposition of peptido-aminobenzophenone (2-o-chlorobenzoyl-4-chloro-N-methyl-N-glycylglycinanilide) and its major benzodiazepine metabolites in dogs.
      M Konishi, T Agoh, T Sato, R Konaka and Y Mori
      Drug Metabolism and Disposition July 1980, 8 (4) 253-259;

  4. Konishi, M

    1. Metabolism and disposition of peptido-aminobenzophenone (2-o-chlorobenzoyl-4-chloro-N-methyl-N-glycylglycinanilide) and its major benzodiazepine metabolites in dogs.
      M Konishi, T Agoh, T Sato, R Konaka and Y Mori
      Drug Metabolism and Disposition July 1980, 8 (4) 253-259;

  5. Krebs, R

    1. Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity.
      R Kahl, D E Friederici, G F Kahl, W Ritter and R Krebs
      Drug Metabolism and Disposition July 1980, 8 (4) 191-196;

  6. Kupferberg, H J

    1. Gas chromatographic-mass spectrometric studies on the metabolic fate of ethotoin in man.
      D L Bius, W D Yonekawa, H J Kupferberg, F Cantor and K H Dudley
      Drug Metabolism and Disposition July 1980, 8 (4) 223-229;

L

  1. Levine, W G

    1. Induction and inhibition of the metabolism and biliary excretion of the azo dye carcinogen, N,N-dimethyl-4-aminoazobenzene (DAB), in the rat.
      W G Levine
      Drug Metabolism and Disposition July 1980, 8 (4) 212-217;

  2. Liu, S J

    1. Effects of phenobarbital and SKF 525-A on the in vivo metabolism of morphine in rats.
      S J Liu and R I Wang
      Drug Metabolism and Disposition July 1980, 8 (4) 260-264;

M

  1. Monkovic, I

    1. Disposition of parenteral butorphanol in man.
      R C Gaver, M Vasiljev, H Wong, I Monkovic, J E Swigor, D R Van Harken and R D Smyth
      Drug Metabolism and Disposition July 1980, 8 (4) 230-235;

  2. Mori, Y

    1. Metabolism and disposition of peptido-aminobenzophenone (2-o-chlorobenzoyl-4-chloro-N-methyl-N-glycylglycinanilide) and its major benzodiazepine metabolites in dogs.
      M Konishi, T Agoh, T Sato, R Konaka and Y Mori
      Drug Metabolism and Disposition July 1980, 8 (4) 253-259;

O

  1. O'Donnell, L

    1. Antipyrine pharmacokinetics in the pregnant rat.
      M Dean, L O'Donnell, S Penglis and B Stock
      Drug Metabolism and Disposition July 1980, 8 (4) 265-267;

P

  1. Pelkonen, O

    1. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
      O Pelkonen, E Sotaniemi, O Tokola and J T Ahokas
      Drug Metabolism and Disposition July 1980, 8 (4) 218-222;

  2. Penglis, S

    1. Antipyrine pharmacokinetics in the pregnant rat.
      M Dean, L O'Donnell, S Penglis and B Stock
      Drug Metabolism and Disposition July 1980, 8 (4) 265-267;

  3. Preston, B D

    1. 2,2',5,5'-Tetrachlorobiphenyl: isolation and identification of metabolites generated by rat liver microsomes.
      B D Preston and J R Allen
      Drug Metabolism and Disposition July 1980, 8 (4) 197-204;

R

  1. Ritter, W

    1. Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity.
      R Kahl, D E Friederici, G F Kahl, W Ritter and R Krebs
      Drug Metabolism and Disposition July 1980, 8 (4) 191-196;

S

  1. Sato, T

    1. Metabolism and disposition of peptido-aminobenzophenone (2-o-chlorobenzoyl-4-chloro-N-methyl-N-glycylglycinanilide) and its major benzodiazepine metabolites in dogs.
      M Konishi, T Agoh, T Sato, R Konaka and Y Mori
      Drug Metabolism and Disposition July 1980, 8 (4) 253-259;

  2. Sauers, M E

    1. Factors influencing dimethylphenobarbital N-demethylation by isolated hepatocytes from untreated and phenobarbital-treated rats.
      M E Sauers, R T Abraham, J D Alvin and M A Zemaitis
      Drug Metabolism and Disposition July 1980, 8 (4) 208-211;

  3. Smith, J L

    1. Timolol metabolism in man and laboratory anamals.
      D J Tocco, A E Duncan, F A deLuna, J L Smith, R W Walker and W J Vandenheuvel
      Drug Metabolism and Disposition July 1980, 8 (4) 236-240;

  4. Smyth, R D

    1. Disposition of parenteral butorphanol in man.
      R C Gaver, M Vasiljev, H Wong, I Monkovic, J E Swigor, D R Van Harken and R D Smyth
      Drug Metabolism and Disposition July 1980, 8 (4) 230-235;

  5. Sotaniemi, E

    1. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
      O Pelkonen, E Sotaniemi, O Tokola and J T Ahokas
      Drug Metabolism and Disposition July 1980, 8 (4) 218-222;

  6. Stock, B

    1. Antipyrine pharmacokinetics in the pregnant rat.
      M Dean, L O'Donnell, S Penglis and B Stock
      Drug Metabolism and Disposition July 1980, 8 (4) 265-267;

  7. Suolinna, E M

    1. Metabolism of sulfanilamide and related drugs in isolated rat and rabbit liver cells.
      E M Suolinna
      Drug Metabolism and Disposition July 1980, 8 (4) 205-207;

  8. Swigor, J E

    1. Disposition of parenteral butorphanol in man.
      R C Gaver, M Vasiljev, H Wong, I Monkovic, J E Swigor, D R Van Harken and R D Smyth
      Drug Metabolism and Disposition July 1980, 8 (4) 230-235;

T

  1. Talbot, K C

    1. Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog.
      J G Dain, S I Bhuta, R A Coombs, K C Talbot and H A Dugger
      Drug Metabolism and Disposition July 1980, 8 (4) 247-252;

  2. Tocco, D J

    1. Timolol metabolism in man and laboratory anamals.
      D J Tocco, A E Duncan, F A deLuna, J L Smith, R W Walker and W J Vandenheuvel
      Drug Metabolism and Disposition July 1980, 8 (4) 236-240;

  3. Tokola, O

    1. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
      O Pelkonen, E Sotaniemi, O Tokola and J T Ahokas
      Drug Metabolism and Disposition July 1980, 8 (4) 218-222;

  4. Tozer, T N

    1. Biodisposition of theophylline. I. Genetic variation in inbred mice.
      C J Betlach and T N Tozer
      Drug Metabolism and Disposition July 1980, 8 (4) 268-270;
    2. Biodisposition of theophylline. II. Effect of aromatic hydrocarbon treatment in mice.
      C J Betlach and T N Tozer
      Drug Metabolism and Disposition July 1980, 8 (4) 271-273;

V

  1. Vandenheuvel, W J

    1. Timolol metabolism in man and laboratory anamals.
      D J Tocco, A E Duncan, F A deLuna, J L Smith, R W Walker and W J Vandenheuvel
      Drug Metabolism and Disposition July 1980, 8 (4) 236-240;

  2. Van Harken, D R

    1. Disposition of parenteral butorphanol in man.
      R C Gaver, M Vasiljev, H Wong, I Monkovic, J E Swigor, D R Van Harken and R D Smyth
      Drug Metabolism and Disposition July 1980, 8 (4) 230-235;

  3. Vasiljev, M

    1. Disposition of parenteral butorphanol in man.
      R C Gaver, M Vasiljev, H Wong, I Monkovic, J E Swigor, D R Van Harken and R D Smyth
      Drug Metabolism and Disposition July 1980, 8 (4) 230-235;

W

  1. Walker, R W

    1. Timolol metabolism in man and laboratory anamals.
      D J Tocco, A E Duncan, F A deLuna, J L Smith, R W Walker and W J Vandenheuvel
      Drug Metabolism and Disposition July 1980, 8 (4) 236-240;

  2. Wang, R I

    1. Effects of phenobarbital and SKF 525-A on the in vivo metabolism of morphine in rats.
      S J Liu and R I Wang
      Drug Metabolism and Disposition July 1980, 8 (4) 260-264;

  3. Wong, H

    1. Disposition of parenteral butorphanol in man.
      R C Gaver, M Vasiljev, H Wong, I Monkovic, J E Swigor, D R Van Harken and R D Smyth
      Drug Metabolism and Disposition July 1980, 8 (4) 230-235;

Y

  1. Yonekawa, W D

    1. Gas chromatographic-mass spectrometric studies on the metabolic fate of ethotoin in man.
      D L Bius, W D Yonekawa, H J Kupferberg, F Cantor and K H Dudley
      Drug Metabolism and Disposition July 1980, 8 (4) 223-229;

Z

  1. Zemaitis, M A

    1. Factors influencing dimethylphenobarbital N-demethylation by isolated hepatocytes from untreated and phenobarbital-treated rats.
      M E Sauers, R T Abraham, J D Alvin and M A Zemaitis
      Drug Metabolism and Disposition July 1980, 8 (4) 208-211;
Back to top

In this issue

Advertisement